Thermage (THRM) Reports Q3 Loss of $0.03, Misses by 2c; Withdraws FY Outlook
More News related to THRM
- Notable Analyst Rating Changes 12/30: AXYS, RDEN Upgraded; DOW, GHL, THRM Downgraded
- Collins Stewart Downgrades Thermage (THRM) to Hold
- Thermage (THRM) Reports Q3 Loss of $0.03, Misses by 2c; Withdraws FY Outlook
- Thermage (THRM) Issues Guidance Below Street View
- Stanford Starts Medical Equipment & Supplies Stocks (SYK, MNT, ZMH, BEAT, more..)
More News related to Earnings
- HNI Corporation (HNI) Tops Q1 EPS by 2c; Revs Light
- Team Health (TMH) Reports Mixed Q4 Results
- Baidu (BIDU) Blows the Lid Off Q4, Shares Jump
- Aspen Insurance (AHL) Posts Q4 adj.-EPS of $1.44, Tops Views
- Acadia Realty Trust (AKR) Misses Q4 FFO by 1c; Guides Below for FY10
Thermage (Nasdaq: THRM) reports Q3 loss of $0.03, 2 cents lower than the analyst estimate of ($0.01). Revenue for the quarter was $13 million, versus the consensus of $14.36 million.
Withdraws full year forecast.
Thermage, Inc. engages in the design, development, manufacture, and marketing of radiofrequency-based equipment and disposable products for non-invasive treatment of wrinkles in the United States and internationally.
Related Categories
EarningsGuidance
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
